Evidence map›Paper›PMID 30523250›Full record

ArticleNature communications2018

GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis.

Otavio Cabral-Marques, Alexandre Marques, Lasse Melvær Giil, Roberta De Vito, Judith Rademacher, Jeannine Günther, Tanja Lange, Jens Y Humrich, Sebastian Klapa, Susanne Schinke and 26 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 18 institutions in 6 countries.

Otavio Cabral-MarquesDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany. otavio.cmarques@gmail.com.
Alexandre MarquesDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Lasse Melvær GiilDeaconess Hospital, University of Bergen, 5006, Bergen, Norway.
Roberta De VitoDepartment of Computer Science, Princeton University, Princeton, NJ, 08540, USA.
Judith RademacherDepartment of Gastroenterology, Infectiology and Rheumatology, Charité University Hospital, Berlin, 12203, Germany.
Jeannine GüntherDept. of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, 10117, Germany.
Tanja LangeDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.ORCID http://orcid.org/0000-0001-8309-2112
Jens Y HumrichDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Sebastian KlapaDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Susanne SchinkeDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Lena F SchimkeDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Gabriele MarschnerDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Silke PitannDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Sabine AdlerUniversity Hospital and University of Bern, Bern, 3012, Switzerland.
Ralf DechendExperimental and Clinical Research Center, a collaboration of Max Delbruck Center for Molecular Medicine and Charité Universitätsmedizin, Berlin, 13125, Germany.
Dominik N MüllerExperimental and Clinical Research Center, a collaboration of Max Delbruck Center for Molecular Medicine and Charité Universitätsmedizin, Berlin, 13125, Germany.
Ioana BraicuDepartment of Nephrology and Cardiovascular Research, Campus Virchow, Charité University Hospital, Berlin, 13353, Germany.
Jalid SehouliDepartment of Gynecology, Charité University Hospital, Berlin and Tumor Bank Ovarian Cancer Network (TOC), Berlin, 13353, Germany.
Kai Schulze-ForsterDepartment of Urology, Charité University Hospital, Berlin, 10117, Germany.
Tobias TrippelDept. of Internal Medicine & Cardiology, Charité University Hospital, Berlin, 13353, Germany.
Carmen ScheibenbogenInstitute for Medical Immunology, Charité University Hospital Berlin, Campus Virchow, Berlin, 10117, Germany.
Annetine StaffUniversity of Oslo and Oslo University Hospital, 0372, Oslo, Norway.
Peter R MertensUniversity Clinic for Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Magdeburg, 39106, Germany.
Madlen LöbelInstitute for Medical Immunology, Charité University Hospital Berlin, Campus Virchow, Berlin, 10117, Germany.
Justin MastroianniDepartment of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Albert Ludwigs University (ALU) of Freiburg, Freiburg, 79106, Germany.ORCID http://orcid.org/0000-0002-1340-7526
Corinna PlattfautSection Experimental Oncology, University Hospital and Medical School (UKSH), University of Lübeck, Lübeck, 23538, Germany.
Frank GieselerSection Experimental Oncology, University Hospital and Medical School (UKSH), University of Lübeck, Lübeck, 23538, Germany.
Duska DragunDepartment of Nephrology and Cardiovascular Research, Campus Virchow, Charité University Hospital, Berlin, 13353, Germany.
Barbara Elizabeth EngelhardtDepartment of Computer Science, Princeton University, Princeton, NJ, 08540, USA.ORCID http://orcid.org/0000-0002-6139-7334
Maria J Fernandez-CabezudoDepartment of Biochemistry College of Medicine and Health Sciences, UAE University, Al Ain, 17666, United Arab Emirates.
Hans D OchsDepartment of Pediatrics, University of Washington School of Medicine, Seattle Children's Research Institute, Seattle, WA, 98191, USA.
Basel K Al-RamadiDepartment of Medical Microbiology and Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, 17666, United Arab Emirates.
Peter LamprechtDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Antje MuellerDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany.
Harald HeideckeDepartment of Urology, Charité University Hospital, Berlin, 10117, Germany.
Gabriela RiemekastenDepartment of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, 23538, Germany. gabriela.riemekasten@uksh.de.
University of Lübeck · DECharité - Universitätsmedizin Berlin · DEMax Delbrück Center · DEPrinceton University · USUnited Arab Emirates University · AEBerlin-Brandenburger Centrum für Regenerative Therapien · DEBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECell Medica (Switzerland) · CHGerman Rheumatism Research Centre · DEOslo University Hospital · NOOtto-von-Guericke-Universität Magdeburg · DESeattle Children's Hospital · USUniversidade Federal de Pernambuco · BRUniversitäres Kinderwunschzentrum Lübeck · DEUniversity Medical Center Freiburg · DEUniversity of Bergen · NOUniversity of Bern · CHUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoantibodies have been associated with autoimmune diseases. However, studies have identified autoantibodies in healthy donors (HD) who do not develop autoimmune disorders. Here we provide evidence of a network of immunoglobulin G (IgG) autoantibodies targeting G protein-coupled receptors (GPCR) in HD compared to patients with systemic sclerosis, Alzheimer's disease, and ovarian cancer. Sex, age and pathological conditions affect autoantibody correlation and hierarchical clustering signatures, yet many of the correlations are shared across all groups, indicating alterations to homeostasis. Furthermore, we identify relationships between autoantibodies targeting structurally and functionally related molecules, such as vascular, neuronal or chemokine receptors. Finally, autoantibodies targeting the endothelin receptor type A (EDNRA) exhibit chemotactic activity, as demonstrated by neutrophil migration toward HD-IgG in an EDNRA-dependent manner and in the direction of IgG from EDNRA-immunized mice. Our data characterizing the in vivo signatures of anti-GPCR autoantibodies thus suggest that they are a physiological part of the immune system.

Indexed as

AgedAlzheimer DiseaseAmino Acid SequenceAnimalsAutoantibodiesFemaleHomeostasisHumansImmunoglobulin GMaleMiceMiddle AgedOvarian NeoplasmsProtein Interaction MapsReceptor, Endothelin AReceptors, G-Protein-CoupledAutoantibodiesImmunoglobulin GReceptor, Endothelin AReceptors, G-Protein-Coupled

Identifiers

PMID30523250
PMCPMC6283882
OpenAlexW2902679943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.